Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48255
Campo DC Valoridioma
dc.contributor.authorCheung, Louisaen_US
dc.contributor.authorAndersen, Malinen_US
dc.contributor.authorGustavsson, Carolinaen_US
dc.contributor.authorOdeberg, Jacoben_US
dc.contributor.authorFernández-Pérez, Leandroen_US
dc.contributor.authorNorstedt, Gunnaren_US
dc.contributor.authorTollet-Egnell, Petraen_US
dc.date.accessioned2018-11-23T20:11:31Z-
dc.date.available2018-11-23T20:11:31Z-
dc.date.issued2007en_US
dc.identifier.issn1471-2199en_US
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/48255-
dc.description.abstractBackground: CD36 is a multiligand receptor involved in various metabolic pathways, including cellular uptake of long-chain fatty acids. Defect function or expression of CD36 can result in dyslipidemia or insulin resistance. We have previously shown that CD36 expression is female-predominant in rat liver. In the present study, hormonal and nutritional regulation of hepatic CD36 expression was examined in male and female rats. Since alternative transcription start sites have been described in murine and human Cd36, we investigated whether alternative CD36 transcripts are differentially regulated in rat liver during these conditions. Results: Sequence information of the rat Cd36 5′-UTR was extended, showing that the gene structure of Cd36 in rat is similar to that previously described in mouse with at least two alternative first exons. The rat Cd36 exon 1a promoter was sequenced and found to be highly similar to murine and human Cd36. We show that alternative first exon usage is involved in the female-predominant expression of CD36 in rat liver and during certain hormonal states that induce CD36 mRNA abundance. Estrogen treatment or continuous infusion of growth hormone (GH) in male rats induced CD36 expression preferentially through the exon 1a promoter. Old age was associated with increased CD36 expression in male rats, albeit without any preferential first exon usage. Intermittent GH treatment in old male rats reversed this effect. Mild starvation (12 hours without food) reduced CD36 expression in female liver, whereas its expression was increased in skeletal muscle. Conclusion: The results obtained in this study confirm and extend our previous observation that GH is an important regulator of hepatic CD36, and depending on the mode of treatment (continuous or intermittent) the gene might be either induced or repressed. We suggest that the effects of continuous GH secretion in females (which is stimulatory) and intermittent GH secretion in males (which is inhibitory) explains the sex-different expression of this gene. Furthermore, a female-specific repression of hepatic CD36 in response to food deprivation was found, which was in contrast to a stimulatory effect in skeletal muscle. This demonstrates a tissue-specific regulation of Cd36.en_US
dc.languageengen_US
dc.relationMecanismos Moleculares y Celulares de Señalización Intracelular en Respuesta A la Hormona de Crecimiento Humana: la Vía Jak (Janus Kinase) Stat (Signal Transducer And Activator Of Transcription) Coen_US
dc.relation.ispartofBMC Molecular Biologyen_US
dc.sourceBMC Molecular Biology,v. 8 (60)en_US
dc.subject32 Ciencias médicasen_US
dc.subject3201 Ciencias clínicasen_US
dc.subject.otherFatty-Acid Translocase/Cd36en_US
dc.subject.otherActivated Receptor-Alphaen_US
dc.subject.otherBinding-Proteinen_US
dc.subject.otherSkeletal-Muscleen_US
dc.subject.otherGene-Expressionen_US
dc.subject.otherGlucose-Metabolismen_US
dc.subject.otherInsulin-Resistanceen_US
dc.subject.otherSignal Transduceren_US
dc.subject.otherPromoteren_US
dc.subject.otherSitesen_US
dc.titleHormonal and nutritional regulation of alternative CD36 transcripts in rat liver - A role for growth hormone in alternative exon usageen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1186/1471-2199-8-60en_US
dc.identifier.scopus34547685783-
dc.identifier.isi000248476300001-
dc.contributor.authorscopusid22936885100-
dc.contributor.authorscopusid14008076600-
dc.contributor.authorscopusid22937446000-
dc.contributor.authorscopusid7004221145-
dc.contributor.authorscopusid6506777525-
dc.contributor.authorscopusid7006397634-
dc.contributor.authorscopusid17339598500-
dc.identifier.issue60-
dc.relation.volume8en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid3267137-
dc.contributor.daisngid4911739-
dc.contributor.daisngid4192435-
dc.contributor.daisngid362916-
dc.contributor.daisngid795544-
dc.contributor.daisngid178539-
dc.contributor.daisngid2143573-
dc.description.numberofpages12en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Cheung, L-
dc.contributor.wosstandardWOS:Andersen, M-
dc.contributor.wosstandardWOS:Gustavsson, C-
dc.contributor.wosstandardWOS:Odeberg, J-
dc.contributor.wosstandardWOS:Fernandez-Perez, L-
dc.contributor.wosstandardWOS:Norstedt, G-
dc.contributor.wosstandardWOS:Tollet-Egnell, P-
dc.date.coverdateJulio 2007en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr3,371
dc.description.jcrqQ2
dc.description.scieSCIE
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.project.principalinvestigatorFernández Pérez, Leandro Francisco-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0001-7802-465X-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameFernández Pérez, Leandro Francisco-
Colección:Artículos
miniatura
Adobe PDF (706,87 kB)
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.